Technical Analysis for CPHI - China Pharma Holdings, Inc.

Grade Last Price % Change Price Change
grade A 0.299 -3.55% -0.01
CPHI closed down 3.55 percent on Friday, January 18, 2019, on 2.17 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical CPHI trend table...

Date Alert Name Type % Chg
Jan 18 Upper Bollinger Band Walk Strength 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Upper Bollinger Band Touch Strength 0.00%
Jan 17 50 DMA Support Bullish -3.55%
Jan 17 Stochastic Reached Overbought Strength -3.55%
Jan 17 Upper Bollinger Band Walk Strength -3.55%
Jan 17 Inside Day Range Contraction -3.55%
Jan 17 Wide Bands Range Expansion -3.55%
Jan 17 Above Upper BB Strength -3.55%

Older signals for CPHI ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. It offers products in the form of dry powder injectibles, liquid injectibles, tablets, capsules, oral solutions, and granules. The company's products are used for the treatment of central nervous system and cerebral cardiovascular, anti-infection and respiratory, and digestive and other diseases. Its products include Bumetanide to treat edema diseases; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Buflomedil Hydrochloride for blood vessel diseases; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and surgery-thrombus deep phlebitis; and Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and lipoprotein blood diseases. The company also provides Cefaclor Dispersible tablets for tympanitis, lower respiratory tract infection; Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Clarithromycin granules and capsules for nasopharynx, respiratory tract, and skin tissue infections; Naproxen Sodium and Pseudophedrine Hydrochloride Sustained Release tablets to relieve cold, sinus, and flu symptoms; Cefalexin capsules for acute tonsillitis; and Anhydroandrographolide for ischemic heart, cerebrovascular, and lipoprotein blood diseases. In addition, it offers Hepatocyte growth-promoting factor; Tiopronin; Omeprazole; Granisetron Hydrochloride injection; Vitamin B6; and Gull Wood extract syrup, as well as Recombined Human Fibroblast Growth Factor products for the repair of wounded skin cells. The company distributes its products through independent regional distributors and sales representatives. China Pharma Holdings, Inc. is based in Haikou, the People's Republic of China.
Is CPHI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.84
52 Week Low 0.19
Average Volume 417,295
200-Day Moving Average 0.265
50-Day Moving Average 0.2783
20-Day Moving Average 0.2506
10-Day Moving Average 0.2789
Average True Range 0.0376
ADX 43.6
+DI 33.0733
-DI 5.823
Chandelier Exit (Long, 3 ATRs ) 0.2222
Chandelier Exit (Short, 3 ATRs ) 0.3078
Upper Bollinger Band 0.3164
Lower Bollinger Band 0.1848
Percent B (%b) 0.87
BandWidth 52.513967
MACD Line 0.0086
MACD Signal Line 0.0
MACD Histogram 0.0086
Fundamentals Value
Market Cap 13.03 Million
Num Shares 43.6 Million
EPS -0.19
Price-to-Earnings (P/E) Ratio -1.55
Price-to-Sales 0.50
Price-to-Book 0.13
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.38
Resistance 3 (R3) 0.38 0.36 0.37
Resistance 2 (R2) 0.36 0.34 0.36 0.36
Resistance 1 (R1) 0.33 0.33 0.32 0.33 0.36
Pivot Point 0.30 0.30 0.30 0.30 0.30
Support 1 (S1) 0.27 0.28 0.26 0.27 0.24
Support 2 (S2) 0.25 0.27 0.25 0.23
Support 3 (S3) 0.22 0.25 0.23
Support 4 (S4) 0.22